Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: FTSE (0.5%), DAX (1.0%), CAC (0.3%), IBEX (0.7%), MIB (0.5%)

Apr 23 ,2026

  • Synopsis

    • European equity markets set to open broadly lower, extending Wednesday's losses. Busy session for earnings/updates with the likes of Nokia, Nestle, STM, Roche, Sanofi, Heineken, Orange, L'Oreal and Essilor Luxottica among those that have reported.

    • Asian equities trading lower Thursday. Tech-heavy benchmarks unable to sustain early gains with South Korea and Taiwan swinging lower. S&P 500 futures weakening afterhours. Crude adding to gains while gold and silver retreating. In macro developments, South Korea economy grew at quickest pace since Q3-2020, underpinned by global semiconductor demand.

    • Strait of Hormuz situation escalated after Iran seized and fired on commercial ships and US reportedly intercepted Iran-linked tankers in Asian waters, contributing to oil strength. Diplomacy prospects remain unclear with Iran insisting on US first ending its blockade and White House waiting on fractured Iranian leadership to present unified proposal. However, NY Times sources said Pakistani officials optimistic about efforts to bring two sides back to negotiations and White House pushed back against reports ceasefire extension will only last 3-5 days.

    • European macro data releases out today include Eurozone, France, German UK Apr flash manufacturing/service PMI, France Apr business/service confidence, UK Mar public sector borrowing requirement, Apr industrial trends orders - CBI, Norway Mar unemployment rate. The Apr Eurozone flash Composite PMI is expected to decline to 50.2 versus Mar's final reading of 50.7. Some analysts also see risk of softer number. UK April flash Composite PMI expected to decline to 49.8 versus Mar's final reading of 50.3. Price-related components likely to show another uptick. A sub-50 composite would mark first contraction in UK private-sector activity since late 2025 and underscore downside risks from geopolitical uncertainty and elevated energy prices.

    • In central banks, Riksbank's Seim speech at 8:00CET at seminar at Nordea and speaks at 13:30 at BUS Assn. conf (Wed-Thu). Bundesbank's Mauderer opening remarks at 9:30CET at Girl's Day Deutsche Börse. Denmark central bank's Nødgaard speech at 16:00CET at JN-data Company Day whilst at the same time the bank's Krogstrup speech at PwC CEO conf. Bundesbank's Nagel speech at 17:00CET at bank organised event title 'Achieving and Maintaining Central Bank Independence and Credibility: Why it Matters'. SNB publishes its Q1 report. In Nicosia, there's an informal European Council (through Fri). EP President Metsola will address heads of state or government on Fri morning and EU's Dombrovskis meets with Bank of Greece's Stournaras and PM Mitsotakis, finance minister Pierrakakis. First trading day for Kongsberg Maritime's (KMAR.NO) shares on Euronext Oslo Børs, spin-off by Kongsberg Gruppen (KOG.NO) on basis of 1 KM share for each KG share held.

  • Politics/Macro/World News

    • European Automobile Manufacturers' Association (ACEA) March new car registrations for EU + EFTA + UK +11.1% y/y

    • UK consumer expectations over the next three months of the state of the economy remained at -53 in April; remains lowest on record -- BRC-Opinium

  • Top company news

    • Earnings/updates

      • Nordics

        • NOKIA.FH (Nokia) -- reports Q1 comparable EPS €0.05 vs consensus €0.04; FY outlook unchanged

        • TEL.NO (Telenor) -- Telenor's subsidiary in Bangladesh Grameenphone announces Q1 2026 results

        • DNB.NO (DNB Bank) --reports Q1 EPS NOK6.54 ex-items vs consensus NOK6.31

        • ESSITY.B.SS (Essity) -- reports Q1 adjusted EPS SEK4.70 vs consensus SEK4.24

        • AUTO.NO (AutoStore Holdings) -- reports Q1 net income $40.5M vs FactSet $36.0M [8 est, $31-43M]

        • BHG.SS (Lightshop) -- reports Q1 EPS (SEK0.10) vs FactSet (SEK0.10) [4 est, (SEK0.13)-(0.05)]

        • PROT.NO (Protector Forsikring) -- reports Q1 net income NOK 165M vs FactSet NOK 217.8M

        • ESSITY.B.SS (Essity) -- reports Q1 adjusted EPS SEK4.70 vs consensus SEK4.24

      • DACHs

        • ROP.SW (Roche Holding) -- reports Q1 Sales CHF14.72B vs consensus CHF14.91B

        • NESN.SW (Nestle) -- reports Q1 revenue CHF21.32B vs consensus CHF21.27B; organic growth +3.5% vs consensus +2.4%; maintains 2026 guidance; notes portfolio actions progressing; agreement reached to sell Blue Bottle Coffee

        • GALD.SW (Galderma Group) -- reports Q1 revenue $1.47B vs FactSet $1.43B [3 est, $1.40-1.47B]; reaffirms FY guidance

        • SCHP.SW (Schindler Holding) -- reports Q1 EPS CHF2.34 vs consensus CHF2.25

        • SGSN.SW (SGS) -- reports Q1 revenue CHF1.75B vs consensus CHF1.73B

        • FTK.GR (flatexDEGIRO) -- reports Q1 net income €53.7M vs FactSet €52.9M [1 est]

        • STM.GR (Stabilus) -- reports prelim Q1 adjusted EBIT €34.1M vs FactSet €29M

        • VONN.SW (Vontobel Holding) -- Q1 trading update: AuM CHF240.1B vs CHF240.7B at end of Dec

      • France

        • SAN.FP (Sanofi) -- reports Q1 Business EPS €1.88 vs consensus €1.78

        • STMPA.FP (STMicroelectronics) -- reports Q1 EPS $0.13 ex-items vs FactSet $0.17 [17 est, $0.10-0.21]

        • ORA.FP (Orange( 00 reports Q1 EBITDAaL €2.60B vs consensus €2.58B; upgrades FY26 EBITDAaL guidance, confirms other financial objectives for 2026

        • DSY.FP (Dassault Systemes) -- reports Q1 non-IFRS EPS €0.30 vs consensus €0.30; guides Q2 (

        • SAF.FP (Safran) -- reports Q1 revenue €8.62B vs consensus €8.28B; FY26 outlook confirmed

        • EDEN.FP (Edenred) -- reports Q1 revenue €730M vs StreetAccount €722M; reconfirms 2026 financial objectives (

        • EL.FP (EssilorLuxottica) -- reports Q1 revenue €7.13B vs StreetAccount €7.15B

        • OR.FP (L'Oreal) -- reports Q1 revenue €12.15B vs StreetAccount €11.63B

        • CA.FP (Carrefour) -- reports Q1 revenue €21.14B vs FactSet €21.74B [2 est, €21.39-22.09B]

        • GTT.FP (Gaztransport & Technigaz) -- reports Q1 revenue €192.5M vs FactSet €198.0M [1 est]; reaffirms its 2026 objectives

        • GFC.FP (Gecina) -- reports Q1 total gross rental income €176.0M vs year-ago €180.0M

        • VRLA.FP (Verallia) -- reports H1 adjusted EBITDA €159.1M, +8% vs year-ago €147.0M

        • IDL.FP (ID Logistics Group) -- reports Q1 revenue €990.7M, +14% vs year-ago €867.8M

        • BIM.FP (bioMerieux) -- reports Q1 revenue €984M vs FactSet €1.04B [2 est, €1.03-1.05B]. Lowers FY sales guidance

      • Benelux

        • HEIA.NA (Heineken) -- reports Q1 net revenue (beia) €6.70B vs consensus €6.70B; FY outlook confirmed

        • BESI.NA (BE Semiconductor) -- reports Q1 EPS €0.65 vs FactSet €0.66 [12 est, €0.60-0.78]

      • Also reporting today

        • Earnings: Benelux: Vivoryon Therapeutics (VVY.NA), Cofinimmo (COFB.BB), Sipef (SIP.BB) Finland: Orion (ORNBV.FH), Fiskars (FSKRS.FH), Scanfil (SCANFL.FH), OLVI (OLVAS.FH), Atria (ATRAV.FH), Verkkokauppa.com (VERK.FH) France: Orange (ORA.FP), Sartorius Stedim Biotech (DIM.FP), Groupe Guillin (ALGIL.FP), MEDIAN Technologies (ALMDT.FP) Germany: SAP (SAP.GR), Sartorius (SRT3.GR), Vossloh (VOS.GR), Nuernberger Beteiligungs (NBG6.GR), Deutsche Rohstoff (DR0.GR), DEAG Deutsche Entertainment (LOU.GR) Norway: Europris (EPR.NO) Sweden: Saab (SAAB.B.SS), Hexagon (HEXA.B.SS), Trelleborg (TREL.B.SS), Beijer Ref (BEIJ.B.SS), Axfood (AXFO.SS), Catena (CATE.SS), Fabege (FABG.SS), HMS Networks (HMS.SS), Bufab (BUFAB.SS), AQ Group (AQ.SS), Husqvarna (HUSQ.B.SS), Gränges (GRNG.SS), Vitrolife (VITR.SS), NCAB Group (NCAB.SS), Norion Bank (NORION.SS), Dometic Group (DOM.SS), New Wave Group (NEWA.B.SS), Vitec Software Group (VIT.B.SS), MilDef Group (MILDEF.SS), JM (JM.SS), Sveafastigheter (SVEAF.SS), MIPS (MIPS.SS), Ovzon (OVZON.SS), NOTE (NOTE.SS), Samhällsbyggnadsbolaget i Norden (SBB.B.SS), Swedencare (SECARE.SS), Humble Group (HUMBLE.SS), Svedbergs Group (SVED.B.SS), Hansa Biopharma (HNSA.SS), Teqnion (TEQ.SS), Studsvik (SVIK.SS), Elanders (ELAN.B.SS), PowerCell Sweden (PCELL.SS), Enea (ENEA.SS), Bulten (BULTEN.SS), Sedana Medical (SEDANA.SS), CDON (CDON.SS), LumenRadio (LUMEN.SS), Bactiguard Holding (BACTI.B.SS), Pricer (PRIC.B.SS), Viaplay Group (VPLAY.A.SS) Southern Europe: Bankinter (BKT.SM), ATRESMEDIA (A3M.SM) UK: J Sainsbury (SBRY.LN), WH Smith (SMWH.LN), Asos (ASC.LN)

        • Trading Update: Benelux: Fugro (FUR.NA), Azelis Group (AZE.BB), Kinepolis Group (KIN.BB) France: VINCI (DG.FP), Compagnie de Saint-Gobain (SGO.FP), Unibail-Rodamco-Westfield (URW.FP), Bolloré (BOL.FP), Ipsen (IPN.FP), Getlink (GET.FP), Renault (RNO.FP), Wendel (MF.FP), Tikehau Capital (TKO.FP), Lisi (FII.FP), Valeo (FR.FP), SEB (SK.FP), Stef (STF.FP), Eramet (ERA.FP), Clariane (CLARI.FP), Fnac Darty (FNAC.FP), Voltalia (VLTSA.FP), Pierre & Vacances (VAC.FP), Savencia (SAVE.FP), Nexity (NXI.FP), Roche Bobois (RBO.FP), Linedata Services (LIN.FP), Cegedim (ALCGM.FP), Deezer (DEEZR.FP), Guerbet (GBT.FP), SergeFerrari Group (SEFER.FP), Vantiva (VANTI.FP) Germany: FORVIA HELLA (HLE.GR) Nordics: Detection Technology (DETEC.FH) Southern Europe: Distribuidora Internacional De Alimentacion (DIA.SM), Seri Industrial (SERI.IM) UK: RELX (REL.LN), London Stock Exchange Group (LSEG.LN), Segro (SGRO.LN), Schroders (SDR.LN), Hikma Pharmaceuticals (HIK.LN), AJ Bell (AJB.LN), Foxtons Group (FOXT.LN)

        • CMD/Events: Volkswagen (VOW3.GR) China Investor Update, Fintel (FNTL.LN)

    • M&A

      • 2371.JP (Kakaku.com) -- EQT AB considering acquisition of Kakaku.com - Bloomberg, citing people familiar with the matter

      • KOG.NO (Kongsberg Gruppen) -- completes demerger of Kongsberg Maritime

      • CNE.LN (Capricorn Energy) -- confirms that it has been in discussions regarding a possible offer for Deltic Energy (DELT.IN)

      • RRTL.GR (RTL Group) -- EC unconditionally approves RTL's acquisition of Sky DACH

      • ALICA.FP (ICAPE Holding) -- ICAPE announces signing and closing of an agreement to acquire the PCB trading activities of TEKUBE in Italy

    • Healthcare

      • REGN (Regeneron) -- Dupixent (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)

      • ROP.SW (Roche Holding) -- FDA grants orphan drug designation to Genentech's divarasib for the treatment of KRAS G12C-positive non-small cell lung cancer

      • ROP.SW (Roche Holding) -- Transcript Intelligence: Roche Holding at American Academy of Neurology Forum

      • IVA.FP (Inventiva) -- names Axel-Sven Malkomes CFO among leadership appointments ahead of expected phase 3 data readout of Lanifibranor

      • SANN.SW (Santhera Pharmaceuticals Holding) -- CEO Dario Eklund to step down; Orlando Oliveira appointed CEO, effective 15-Jul

      • XVIVO.SS (Xvivo Perfusion) -- announces data from PRESERVE Trial

      • XVIVO.SS (Xvivo Perfusion) -- presents results from HOPE-at-Heart clinical trial using hypothermic oxygenated perfusion (Hope) in direct procurement DCD heart transplantation

    • Other

      • ASML.NA (ASML Holding) -- TSMC (2330.TT) says it won't use ASML's latest generation machine until 2029 -- Reuters

      • UBSG.SW (UBS Group) -- UBS statement on regulatory capital announcements made by Swiss government (22-Apr, 17:00 CEST)

      • BA.LN (BAE Systems) -- awarded $45.5M US Navy contract modification

      • ML.FP (Cie Generale des Etablissements Michelin SA) -- Michelin publishes global tire market data for March

      • ESSITY.B.SS (Essity) -- initiates a new program to buy back Class B shares in for SEK 3B

      • NEL.NO (NEL ASA) -- NEL received a purchase order for PEM electrolyser equipment with total value of ~ $7M

      • MIPS.SS (MIPS) -- Karin Rosental to step down as CFO of MIPS, effective 22-Oct-26

      • RRTL.GR (RTL Group) -- raises long-term subscriber target following EC approval of Sky Deutschland acquisition - Handelsblatt

      • European Automobile Manufacturers' Association (ACEA) March new car registrations for EU + EFTA + UK +11.1% y/y

      • Freddie Mac and Fannie Mae begin accepting VantageScore 4.0

  • Key rating changes

    • Upgrades

      • Jefferies upgrades CRDA.LN

      • LUMO.FH (Kojamo) -- to neutral from underweight at JPMorgan

      • METSO.FH (Metso Corp.) -- to buy from hold at Handelsbanken

      • ABBN.SW (ABB Limited) -- to hold from sell at Deutsche Bank

    • Downgrades

      • IHP.LN (Integrafin Holdings) -- to hold from buy at Shore Capital Stockbrokers

      • REG1V.FH (Revenio Group) -- to hold from buy at SEB

      • SUBC.NO (Subsea 7) -- to sell from buy at SEB

      • ENT.LN (Entain) -- to neutral from buy at BofA

  • Data

    • Nikkei (0.80%) to 59108.12

    • Hang Seng (0.91%) to 25925.27

    • Shanghai Composite (0.29%) to 4094.48

    • S&P futures (34.8) vs prior close of 7171.3

    • €-$ (0.0000) or (0.00%) to 1.1708

    • $-¥ +0.06 or +0.03% to 159.54

    • €-¥ +0.10 or +0.05% to 186.78

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.